170 related articles for article (PubMed ID: 34710826)
41. Highly sensitive inhibition of hTERT mRNA expression and telomerase activity by DNA-signal-peptide conjugates.
Kubo T; Bakalova R; Zhelev Z; Ohba H; Fujii M
Nucleic Acids Symp Ser (Oxf); 2005; (49):337-8. PubMed ID: 17150771
[TBL] [Abstract][Full Text] [Related]
42. Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52.
Cale JM; Greer K; Fletcher S; Wilton SD
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801742
[TBL] [Abstract][Full Text] [Related]
43. [Inhibiting expression of human telomerase reverse transcriptase promotes degradation of survivin protein].
Mei ZZ; Zheng XF; Dong Y; Song Y; Liu B; Sun GJ; Sun ZX
Ai Zheng; 2005 May; 24(5):525-30. PubMed ID: 15890091
[TBL] [Abstract][Full Text] [Related]
44. Bioinformatics analysis of Exonic Splicing Enhancers (ESEs) for predicting potential regulatory elements of hTERT mRNA splicing.
Wang F; Chang GM; Geng X
Eur Rev Med Pharmacol Sci; 2014; 18(4):526-36. PubMed ID: 24610620
[TBL] [Abstract][Full Text] [Related]
45. Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.
Wang Y; Shen W; Liang XH; Crooke ST
Nucleic Acid Ther; 2019 Dec; 29(6):343-358. PubMed ID: 31429620
[TBL] [Abstract][Full Text] [Related]
46. miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells.
Ohira T; Naohiro S; Nakayama Y; Osaki M; Okada F; Oshimura M; Kugoh H
Sci Rep; 2015 Feb; 5():8201. PubMed ID: 25643913
[TBL] [Abstract][Full Text] [Related]
47. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
48. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.
Shen W; De Hoyos CL; Sun H; Vickers TA; Liang XH; Crooke ST
Nucleic Acids Res; 2018 Mar; 46(5):2204-2217. PubMed ID: 29390093
[TBL] [Abstract][Full Text] [Related]
49. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
[TBL] [Abstract][Full Text] [Related]
50. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
[TBL] [Abstract][Full Text] [Related]
51. Physiological and pathological significance of human telomerase reverse transcriptase splice variants.
Bollmann FM
Biochimie; 2013 Nov; 95(11):1965-70. PubMed ID: 23933091
[TBL] [Abstract][Full Text] [Related]
52. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108
[TBL] [Abstract][Full Text] [Related]
53. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model.
Ding Z; Green AG; Yang X; Chernenko G; Tang SC; Pater A
Exp Cell Res; 2002 Jan; 272(2):185-91. PubMed ID: 11777343
[TBL] [Abstract][Full Text] [Related]
54. A chemical view of oligonucleotides for exon skipping and related drug applications.
Järver P; O'Donovan L; Gait MJ
Nucleic Acid Ther; 2014 Feb; 24(1):37-47. PubMed ID: 24171481
[No Abstract] [Full Text] [Related]
55. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells.
Yi X; Shay JW; Wright WE
Nucleic Acids Res; 2001 Dec; 29(23):4818-25. PubMed ID: 11726691
[TBL] [Abstract][Full Text] [Related]
56. Pluronic-PEI copolymers enhance exon-skipping of 2'-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice.
Wang M; Wu B; Lu P; Tucker JD; Milazi S; Shah SN; Lu QL
Gene Ther; 2014 Jan; 21(1):52-9. PubMed ID: 24131982
[TBL] [Abstract][Full Text] [Related]
57. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
Mercatante DR; Sazani P; Kole R
Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
[TBL] [Abstract][Full Text] [Related]
58. [Effect of antisense oligodeoxynucleotide targeting hTERT on telomerase activity and cell apoptosis in K562 cell line].
Ying XY; Fang MY; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):48-53. PubMed ID: 18315899
[TBL] [Abstract][Full Text] [Related]
59. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
Schmajuk G; Sierakowska H; Kole R
J Biol Chem; 1999 Jul; 274(31):21783-9. PubMed ID: 10419493
[TBL] [Abstract][Full Text] [Related]
60. Upregulation of functional Kv11.1 isoform expression by inhibition of intronic polyadenylation with antisense morpholino oligonucleotides.
Gong Q; Stump MR; Zhou Z
J Mol Cell Cardiol; 2014 Nov; 76():26-32. PubMed ID: 25128783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
